Bath & Body Works, Inc. (NYSE:BBWI) Receives Average Rating of “Hold” from Analysts

Bath & Body Works, Inc. (NYSE:BBWI) has received an average recommendation of “Hold” from the nineteen brokerages that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $25.1667.

BBWI has been the subject of a number of research analyst reports. Citigroup decreased their price objective on shares of Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a report on Friday, November 21st. Wells Fargo & Company decreased their price target on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, November 21st. Robert W. Baird reiterated a “neutral” rating and issued a $19.00 price target (down previously from $33.00) on shares of Bath & Body Works in a report on Thursday, November 20th. Bank of America dropped their price objective on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Thursday, November 20th. Finally, Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $38.00 to $17.00 in a report on Friday, November 21st.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, Director Francis Hondal acquired 3,343 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $14.99 per share, for a total transaction of $50,111.57. Following the completion of the purchase, the director owned 21,554 shares in the company, valued at approximately $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Stephen D. Steinour acquired 6,700 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $14.86 per share, for a total transaction of $99,562.00. Following the completion of the acquisition, the director owned 48,175 shares of the company’s stock, valued at $715,880.50. This trade represents a 16.15% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders acquired 33,513 shares of company stock worth $500,442. Company insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently bought and sold shares of BBWI. First Horizon Corp purchased a new position in Bath & Body Works in the third quarter worth $29,000. Stonehage Fleming Financial Services Holdings Ltd acquired a new stake in shares of Bath & Body Works in the 2nd quarter worth $33,000. SVB Wealth LLC purchased a new position in Bath & Body Works during the 1st quarter worth $35,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Up 2.2%

BBWI opened at $19.01 on Thursday. The business has a fifty day moving average of $23.23 and a 200 day moving average of $27.29. The stock has a market cap of $3.89 billion, a P/E ratio of 5.85, a PEG ratio of 0.70 and a beta of 1.51. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The firm’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Equities analysts anticipate that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.2%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio is presently 24.62%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.